| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/21/2001 | EP1085084A1 Chondrocytes compositions, preparation and use |
| 03/21/2001 | EP1085082A1 Methods and compositions for chondrocytes preservation and uses therefor |
| 03/21/2001 | EP1085081A1 Method for the transport of cells and grafts |
| 03/21/2001 | EP1084709A1 Oral recombinant lactobacilli vaccines |
| 03/21/2001 | EP1084707A1 Probiotic E. coli strain |
| 03/21/2001 | EP1084278A1 Detection of dna, rna and proteins |
| 03/21/2001 | EP1084251A2 Attenuated pestiviruses |
| 03/21/2001 | EP1084246A2 Biological material for preparing pharmaceutical compositions for treating mammals |
| 03/21/2001 | EP1084236A1 Novel adenoviral vectors for gene therapy |
| 03/21/2001 | EP1084232A1 Genetically-modified fibroblasts and the use thereof |
| 03/21/2001 | EP1084230A2 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
| 03/21/2001 | EP1084227A1 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
| 03/21/2001 | EP1083934A2 Gene therapy method |
| 03/21/2001 | EP1083930A1 Insulin supplemented infant formula |
| 03/21/2001 | EP1083911A2 Use of adeno-associated viruses for decreasing the radiotherapy-induced or chemotherapy-induced resistance in cancer patients |
| 03/21/2001 | EP1083910A1 nrdE |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP1083856A1 Topical transdermal treatments |
| 03/21/2001 | EP0840781A4 Methods and devices for the removal of psoralens from blood products |
| 03/21/2001 | EP0797678B1 Hybrid adenovirus-aav virus and method of use thereof |
| 03/21/2001 | CN1288382A Sea cucumber carotenoid lipid fraction products and method of use |
| 03/21/2001 | CN1288370A Mixture contg. honey, at least one essential oil and/or at least one essential oil derivative |
| 03/21/2001 | CN1287975A Health-care stone |
| 03/21/2001 | CN1287888A Tourmaline and its prepn. method |
| 03/21/2001 | CN1287858A Traditional Chinese medicinal composition for treating hepatitis and its prepn. method |
| 03/21/2001 | CN1287853A Bolus for bone setting and activating collaterals |
| 03/21/2001 | CN1287844A Traditional Chinese medicinal powder for treating pharyngolaryngeeal disease |
| 03/21/2001 | CN1287841A 'Anshenwan' for treating male infertility |
| 03/21/2001 | CN1287838A Health-care products extracted from ostrich blood, penis orchis |
| 03/21/2001 | CN1287837A Forest forg's sprawn and its application |
| 03/21/2001 | CN1287836A Doukey-hide gelatin capsule |
| 03/21/2001 | CN1063490C Preparation process for full composition pearl crude liquid and pearl powder |
| 03/21/2001 | CN1063340C Glycosuria lowering capasule contg. pearl and Radix astragali and its prodn. method |
| 03/21/2001 | CN1063334C Nutrition liquor contg. silk moth essence |
| 03/21/2001 | CN1063333C Liniment and its prepn. method |
| 03/21/2001 | CN1063332C Medicinal composition for curing eye injury |
| 03/21/2001 | CN1063330C Process for extracting ant extract |
| 03/21/2001 | CN1063329C Antiphlogistic tissue regenerating ointment for external use |
| 03/21/2001 | CN1063328C Medicine for removing tumour and preparing process thereof |
| 03/21/2001 | CN1063327C Application for RNA enzyme inhibition factor used as tumour inhibitor |
| 03/21/2001 | CN1063326C Traditional Chinese medicine for treating children's cough |
| 03/21/2001 | CN1063325C Oral patent chinese medicine for treating psoriasis |
| 03/21/2001 | CN1063324C Powder medicine for curing fluorine-poisoning of domestic animals |
| 03/20/2001 | US6204251 Ocular gene therapy |
| 03/20/2001 | US6204248 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 03/20/2001 | US6204060 Viral vectors and line for gene therapy |
| 03/20/2001 | US6204059 AAV capsid vehicles for molecular transfer |
| 03/20/2001 | US6204058 Treatment of autoimmune diseases |
| 03/20/2001 | US6204053 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204045 Genetically engineered infectious laryngotracheitis virus; for the development of vaccines against viral disease |
| 03/20/2001 | US6204010 Flea protease proteins, nucleic acid molecules, and uses thereof |
| 03/20/2001 | US6203975 Adenovirus and method of use thereof |
| 03/20/2001 | US6203789 Treating erythrocytes with s-nitroso-cysteine, homocysteine, or cysteinylglycine to reduce blood pressure |
| 03/20/2001 | US6202546 Liquid colostrum for dairy products |
| 03/15/2001 | WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | WO2001018206A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | WO2001018193A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018169A2 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases |
| 03/15/2001 | WO2001018053A1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 03/15/2001 | WO2001018035A2 Muc-1 derived peptides |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001017596A1 Method of treating cardio pulmonary diseases with no group compounds |
| 03/15/2001 | WO2001017538A1 Use of oyster flesh enzymatic hydrolysates for preparing compositions eliminating free radicals |
| 03/15/2001 | WO2001017537A2 Methods and compositions for reducing immune response |
| 03/15/2001 | WO2001017536A2 Novel autogenous vaccines used to obtain an immune tolerance |
| 03/15/2001 | WO2001017535A2 Enriched fraction from a porcine liver extract for treating human diseases |
| 03/15/2001 | WO2001017366A1 Improving condition of elderly pets |
| 03/15/2001 | WO2000078353A3 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 03/15/2001 | WO2000073440A8 Pollinosis-associated gene 787 |
| 03/15/2001 | WO2000066178A9 Lim mineralization protein splice variants |
| 03/15/2001 | WO2000044398A3 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions |
| 03/15/2001 | DE19943644A1 Anwendung eines probiotischen Escherichia coli Isolates zur Hemmung der Shiatoxinproduktion und des Wachstums von enterohämorrhagischen E.coli (EHEC)-Stämmen Application of a probiotic Escherichia coli isolate Shiatoxinproduktion and for inhibiting the growth of enterohaemorrhagic E. coli (EHEC) strains |
| 03/15/2001 | DE19943488A1 Agent for the treatment and prevention of pigeon diseases contains colony-producing lactobacilli |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384663A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | CA2383776A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2382138A1 Methods and compositions for reducing immune response |
| 03/15/2001 | CA2349434A1 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 03/14/2001 | EP1082964A1 Lactic acid bacterium-containing compositions, drugs and foods |
| 03/14/2001 | EP1082908A1 Additives for crustacean or fish feeds and feeds |
| 03/14/2001 | EP1082445A2 Adeno-associated viral vector-mediated expression of factor viii activity |
| 03/14/2001 | EP1082441A1 Mycobacterial n-acetyltransferases |
| 03/14/2001 | EP1082412A2 Transfected cells and methods for treating diabetes |
| 03/14/2001 | EP1082411A2 Method for preparation and in vivo administration of antigen presenting cell composition |
| 03/14/2001 | EP1082410A1 Human cd45+ and/or fibroblast + mesenchymal stem cells |
| 03/14/2001 | EP1082141A1 Cd40 binding molecules and ctl peptides for treating tumors |
| 03/14/2001 | EP1082134A2 Composition comprising tumor cells and extracts and method of using thereof |
| 03/14/2001 | EP1082129A1 Method for the treatment of fertility disorders |
| 03/14/2001 | EP1082091A1 Use of micro-organism extracts in cosmetic or pharmaceutical compositions |
| 03/14/2001 | EP1024872A4 Systems and methods for collecting diluted mononuclear cells |
| 03/14/2001 | EP0980202A4 Methods for viral inactivation and compositions for use in same |
| 03/14/2001 | EP0808203B1 Centrifuge with annular filter |
| 03/14/2001 | EP0804601B1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
| 03/14/2001 | EP0701455B1 Plasma-like solution |
| 03/14/2001 | CN1287496A Method for inactivation of microorganisms using photosensitizers |
| 03/14/2001 | CN1287166A Separation, extracorporeal culture, preparation and application of human primitive mesenchymal stem cell population |